Company registration number 07277582 (England and Wales)
DEMANDSCIENCE UK LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
DEMANDSCIENCE UK LIMITED
COMPANY INFORMATION
Directors
Mrs P J Carter
Mr G M Jordan
(Appointed 11 February 2025)
Mr E N Leutz
(Appointed 12 June 2025)
Mr J Lin
(Appointed 12 June 2025)
Company number
07277582
Registered office
125 Old Broad Street
London
United Kingdom
EC2N 1AR
Auditor
Darnells Audit Limited
Quay House
Quay Road
Newton Abbot
Devon
TQ12 2BU
DEMANDSCIENCE UK LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2 - 3
Independent auditor's report
4 - 6
Statement of comprehensive income
7
Balance sheet
8
Statement of changes in equity
9
Notes to the financial statements
10 - 21
DEMANDSCIENCE UK LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 1 -
The directors present the strategic report for the year ended 31 December 2024.
Fair review of the business
The directors consider that the key performance indicators are Turnover, Gross margin, Earnings before interest, tax, depreciation and amortisation (EBITDA) and Net assets. Together these demonstrate the financial performance and strength of the company. An overview of these indicators for both the current and prior periods are given below:
2024
2023
£
£
Turnover
7,072,080
10,880,007
Gross profit
7,063,973
10,850,007
Gross margin
99.89%
99.72%
EBITDA
410,383
1,430,881
Net assets
521,621
1,827,033
The company's sales by value have decreased by 35% compared with 2023. The company provides services to the DemandScience Group and its level of turnover is therefore linked to the performance of other group companies.
The company's gross profit has decreased by £3.79 million or 34.9% compared to 2023 as a result the decrease in sales, The gross margin has increased from 99.72% for 2023 to 99.89% this year.
The decrease in both EBITDA and Profit before tax compared with the previous year is the result of the decreases in both sales value and gross profit and the write off of inter-company loans of £0.8 million.
The retained loss for the year is £0.41 million compared with a retained profit of £1.0 million for the previous year.
The company has net current liabilities of £0.24 million. This is mainly due to the early adoption of the September 2024 edition of FRS 102, changing the the way operating leases are accounted for, and resulting in a current liability lease creditor of £0.5m.
Net assets have decreased by £1.31 million from £1.83 million at 31 December 2023 to £0.52 miillion.
Principal risks and uncertainties
The company's principal operational risk is that group companies to which it provides services will experience falls in demand as result of economic and political factors in the USA and globally which create uncertainty, such as the war in Ukraine, and fluctuating levels of inflation and interest rates. These factors provide challenges in making long-term predictions of performance.
The company's IT risks include the loss of data. The company manages its IT risks through investing in anti-virus software and appropriate firewalls, and regularly backing up its data to a secure environment.
Mrs P J Carter
Director
20 August 2025
DEMANDSCIENCE UK LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
The directors present their annual report and financial statements for the year ended 31 December 2024.
Principal activities
The principal activity of the company is the provision of staff that specialise in general administration, research and development, sales and lead generation to group companies.
Results and dividends
The results for the year are set out on page 7.
Ordinary dividends were paid amounting to £476,895. The directors do not recommend payment of a further dividend.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Mr W B Harrigan Jr
(Resigned 1 November 2024)
Mrs P J Carter
Mr G M Jordan
(Appointed 11 February 2025)
Mr E N Leutz
(Appointed 12 June 2025)
Mr J Lin
(Appointed 12 June 2025)
Financial instruments
The company's principal financial instruments comprise bank balances, creditors, and, loans to and from other group companies. The main purpose of these instruments is to raise funds for the company's operations and to finance its operations.
Due to the nature of the financial instruments used by the company, there is no exposure to price risk.
The directors' approach to managing other risks applicable to the financial instruments concerned is as follows:
In respect of bank balances, the liquidity risk is managed by the monitoring of forecast income and expenditure,
Trade debtors represent sales of services invoiced monthly to other group members and therefore there is no significant credit and cash flow risk. Trade creditors risk is managed by ensuring that there are sufficient funds available to meet amounts as they fall due. Loans by and to the group are unsecured and interest free.
Auditor
Darnells Audit Limited were appointed as auditor to the company and in accordance with section 485 of the Companies Act 2006, a resolution proposing that they be re-appointed will be put at a General Meeting.
Statement of directors' responsibilities
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.
DEMANDSCIENCE UK LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
Medium-sized companies exemption
This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.
On behalf of the board
Mrs P J Carter
Director
20 August 2025
DEMANDSCIENCE UK LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF DEMANDSCIENCE UK LIMITED
- 4 -
Opinion
We have audited the financial statements of Demandscience UK Limited (the 'company') for the year ended 31 December 2024 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its loss for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
DEMANDSCIENCE UK LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF DEMANDSCIENCE UK LIMITED
- 5 -
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report and the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit; or
the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the directors' report and from the requirement to prepare a strategic report.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting form error, as fraud may involve deliberate concealment by, for example, forgery, misrepresentation or through collusion.
However, the primary responsibility for the prevention and detection of fraud rests with those charged with governance of the company and management.
There are no laws and regulations identified as being of significance in the context of the company.
The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
Enquiry of management and those charged with governance around actual and potential litigation and claims.
Enquiry of management in tax and compliance functions to identify any instances of non-compliance with laws and regulations.
Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations.
Auditing the risk of management override of controls, including through testing journal entries and other adjustments for appropriateness, and evaluating the business rationale of significant transactions outside the normal course of business.
DEMANDSCIENCE UK LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF DEMANDSCIENCE UK LIMITED
- 6 -
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Sean Murphy BA FCA
Senior Statutory Auditor
For and on behalf of Darnells Audit Limited
25 August 2025
Quay House
Quay Road
Newton Abbot
Devon
TQ12 2BU
DEMANDSCIENCE UK LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
2024
2023
Notes
£
£
Turnover
3
7,072,080
10,880,007
Cost of sales
(8,107)
(30,000)
Gross profit
7,063,973
10,850,007
Administrative expenses
(6,460,657)
(9,587,024)
Exceptional item
4
(795,617)
Operating (loss)/profit
5
(192,301)
1,262,983
Interest payable and similar expenses
8
(59,247)
(Loss)/profit before taxation
(251,548)
1,262,983
Tax on (loss)/profit
9
(162,095)
(262,744)
(Loss)/profit for the financial year
(413,643)
1,000,239
The profit and loss account has been prepared on the basis that all operations are continuing operations.
DEMANDSCIENCE UK LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 8 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
11
3,866,769
815,305
Current assets
Debtors
12
7,028,094
8,550,873
Cash at bank and in hand
57,878
7,245
7,085,972
8,558,118
Creditors: amounts falling due within one year
13
(7,327,852)
(7,491,340)
Net current (liabilities)/assets
(241,880)
1,066,778
Total assets less current liabilities
3,624,889
1,882,083
Creditors: amounts falling due after more than one year
14
(3,067,785)
-
Provisions for liabilities
Deferred tax liability
16
35,483
55,050
(35,483)
(55,050)
Net assets
521,621
1,827,033
Capital and reserves
Called up share capital
18
2
2
Profit and loss reserves
521,619
1,827,031
Total equity
521,621
1,827,033
These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.
The financial statements were approved by the board of directors and authorised for issue on 20 August 2025 and are signed on its behalf by:
Mrs P J Carter
Director
Company registration number 07277582 (England and Wales)
DEMANDSCIENCE UK LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 January 2023
2
826,792
826,794
Year ended 31 December 2023:
Profit and total comprehensive income
-
1,000,239
1,000,239
Balance at 31 December 2023
2
1,827,031
1,827,033
Impact of transition to September 2024 edition of FRS 102 at 1 January 2024
(414,874)
(414,874)
Adjusted Balance at 1 January 2024
2
1,412,157
1,412,161
Year ended 31 December 2024:
Loss and total comprehensive income
-
(413,643)
(413,643)
Dividends
10
-
(476,895)
(476,895)
Balance at 31 December 2024
2
521,619
521,621
DEMANDSCIENCE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 10 -
1
Accounting policies
Company information
Demandscience UK Limited is a private company limited by shares incorporated in England and Wales. The registered office and busisness address is 125 Old Broad Street, London, United Kingdom, EC2N 1AR.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:
Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;
Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues: Interest income/expense and net gains/losses for financial instruments not measured at fair value; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;
Section 26 ‘Share based Payment’: Share-based payment expense charged to profit or loss, reconciliation of opening and closing number and weighted average exercise price of share options, how the fair value of options granted was measured, measurement and carrying amount of liabilities for cash-settled share-based payments, explanation of modifications to arrangements;
Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.
The financial statements of the company are consolidated in the financial statements of DemandScience Holdings UK Limited. These consolidated financial statements are available from its registered office, 26th Floor, 125 Old Broad Street, London EC2N 1AR.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Turnover
The company generates its revenue from the provision of general administration, research and development and sales services to a company in the wider worldwide group under the terms of a service contract.
The customer is based in the United States of America.
Revenue is calculated on a cost plus mark-up basis.
The company has no other sources of income.
The company satisfies its performance obligation upon completion of the service.
Payments is typically due within 60 days of the invoice date.
DEMANDSCIENCE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 11 -
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Leasehold improvements
Over the length of the 10 year lease
Fixtures, fittings & equipment
7 years straight Line
Computer equipment
3 or 4 years straight Line
Right-of-use-asset
Over the length of the 10 year lease
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
1.6
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.7
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.
DEMANDSCIENCE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 12 -
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Other financial liabilities
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.
DEMANDSCIENCE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 13 -
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
1.8
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.9
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.10
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.11
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
DEMANDSCIENCE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 14 -
1.12
Leases
From 1 January 2024 the company adopted the September 2024 edition of FRS 102 and as such operating leases were brought onto the company's balance sheet with a right-of-use asset and an associated lease liability recognised.
At the commencement date the right-of-use asset is measured at cost, which is equal to the amount of the initial measurement of the lease liability plus payments made less incentives received before the commencement date of the lease.
The lease liability is initially measured at the present value of future lease payments. The present value of unpaid lease payments is the total lease payments unpaid, discounted at the company's incremental borrowing rate.
The right-of-use asset is subsequently measured at cost less accumulated depreciation and impairment losses, adjusted for any remeasurement of the lease liability arising from a reassessment of the lease term, revision to lease break assumptions or revision to in-substance fixed lease repayments.
The depreciation and impairment accounting policies applied to the right-of-use assets are consistent with those applied to the respective tangible asset categories with depreciation charged on a straight-line basis over the lease term.
The lease liability is subsequently measured by increasing the carrying amount to reflect interest on the lease liability, reducing the carrying amount to reflect the lease payments made and adjusted to reflect any reassessment of the lease term. The interest expense is recognised in the profit and loss account.
The company has elected to account for short term leases expiring within 12 months using the practical expedients contained in the September 2024 edition of FRS 102. Instead of recognising a right-of-use asset and a lease liability, the lease payments in relation to such leases are recognised as an expense in Profit and Loss on a straight-line basis over the lease term.
This represents a change in accounting policy - see note 2 to the financial statements.
1.13
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2
Change in accounting policy
The September 2024 edition of FRS 102 was adopted by the company on 1 January 2024 and the modified retrospective approach was applied on transition. Under the modified retrospective approach, a lessee does not restate the comparative figures; instead the company applies the new standard from the beginning of the current year.
The cumulative effect of adopting the September 2024 edition of FRS 102, comprising the recognition of the right-of-use asset with a net book value of £3,657,118 (see note 11 to the financial statements) and the associated lease liability of £3,573,803, has been recognised as an adjustment to the opening balance of retained earnings at 1 January 2024 of £414,874 (see the Statement of Changes in Equity).
DEMANDSCIENCE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 15 -
3
Turnover
2024
2023
£
£
Turnover analysed by geographical market
United Kingdom
-
885,403
Ireland
-
253,833
United States of America
7,072,080
9,127,333
Switzerland
-
613,438
7,072,080
10,880,007
The entire turnover in the current year derives from sales to companies in the wider, world-wide group. In the comparative year sales were made to non-group customers in addition to companies within the group.
4
Exceptional item
2024
2023
£
£
Expenditure
Inter-company debt written off
795,617
-
During the year the company has written off irrecoverable loans to fellow group undertakings totalling £795,617.
5
Operating (loss)/profit
2024
2023
Operating (loss)/profit for the year is stated after charging/(crediting):
£
£
Exchange gains
(183)
(108,094)
Fees payable to the company's auditor for the audit of the company's financial statements
7,500
7,500
Depreciation of tangible fixed assets
602,684
167,898
Loss on disposal of tangible fixed assets
2,970
-
Operating lease charges
-
372,976
6
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Number
Number
48
64
DEMANDSCIENCE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
6
Employees
(Continued)
- 16 -
Their aggregate remuneration comprised:
2024
2023
£
£
Wages and salaries
4,407,244
6,936,474
Social security costs
554,862
929,559
Pension costs
55,886
77,494
5,017,992
7,943,527
7
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
422,879
Remuneration disclosed above include the following amounts paid to the highest paid director:
2024
2023
£
£
Remuneration for qualifying services
-
212,275
The directors are remunerated by another company in the group.
8
Interest payable and similar expenses
2024
2023
£
£
Interest on finance leases and hire purchase contracts
59,247
-
9
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
185,000
263,338
Adjustments in respect of prior periods
4,456
(6,138)
Group tax relief
(7,794)
27,807
Total current tax
181,662
285,007
Deferred tax
Origination and reversal of timing differences
(19,567)
(22,263)
Total tax charge
162,095
262,744
DEMANDSCIENCE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
9
Taxation
(Continued)
- 17 -
The actual charge for the year can be reconciled to the expected (credit)/charge for the year based on the profit or loss and the standard rate of tax as follows:
2024
2023
£
£
(Loss)/profit before taxation
(251,548)
1,262,983
Expected tax (credit)/charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.50%)
(62,887)
296,801
Tax effect of expenses that are not deductible in determining taxable profit
224,332
19,922
Adjustments in respect of prior years
4,456
(6,138)
Group relief
(7,794)
(64,076)
Permanent capital allowances in excess of depreciation
(108,546)
16,235
Depreciation on assets not qualifying for tax allowances
112,534
Taxation charge for the year
162,095
262,744
10
Dividends
2024
2023
£
£
Final paid
476,895
DEMANDSCIENCE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 18 -
11
Tangible fixed assets
Leasehold improvements
Fixtures, fittings & equipment
Computer equipment
Right-of-use-asset
Total
£
£
£
£
£
Cost
At 1 January 2024
762,783
284,137
184,555
1,231,475
Disposals
(2,579)
(48,729)
(51,308)
Recognised on transfer to FRS 102 at 1 January 2024
4,540,103
4,540,103
At 31 December 2024
762,783
281,558
135,826
4,540,103
5,720,270
Depreciation and impairment
At 1 January 2024
168,420
108,778
138,972
416,170
Recognised on transfer to FRS 102 at 1 January 2024
-
-
-
882,985
Depreciation charged in the year
76,508
40,257
35,784
450,135
602,684
Eliminated in respect of disposals
(2,228)
(46,110)
(48,338)
At 31 December 2024
244,928
146,807
128,646
1,333,120
1,853,501
Carrying amount
At 31 December 2024
517,855
134,751
7,180
3,206,983
3,866,769
At 31 December 2023
594,363
175,359
45,583
815,305
The right-of-use-asset represents the lease of property occupied by the company, recognised on 1 January 2024 at a net book value of £3,657,118.
12
Debtors
2024
2023
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
6,629,395
8,057,963
Other debtors
31,700
46,436
Prepayments and accrued income
199,768
279,243
6,860,863
8,383,642
2024
2023
Amounts falling due after more than one year:
£
£
Other debtors
167,231
167,231
Total debtors
7,028,094
8,550,873
Amounts owed by group undertakings are unsecured, interest free and repayable on demand.
DEMANDSCIENCE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 19 -
13
Creditors: amounts falling due within one year
2024
2023
Notes
£
£
Lease obligations
15
506,018
Trade creditors
37,953
47,616
Amounts owed to group undertakings
6,476,863
6,476,863
Corporation tax
57,064
194,402
Other taxation and social security
160,464
323,601
Accruals and deferred income
89,490
448,858
7,327,852
7,491,340
Amounts owed to group undertakings are unsecured, interest free and repayable on demand.
14
Creditors: amounts falling due after more than one year
2024
2023
Notes
£
£
Lease obligations
15
3,067,785
15
Lease obligations
At 1 January 2024
Additions
Interest (Note 8)
Capital repaid
At 31 December 2024
£
£
£
£
£
Leasehold property
-
4,540,103
59,247
(1,025,547)
3,573,803
The actual cash flows of the lease repayments are due as follows:
2024
2023
£
£
Within one year
506,018
In two to five years
2,104,834
In over five years
962,951
3,573,803
The lease obligations represent the present value of the minimum lease payments, discounted at the company's incremental borrowing rate of 1.6%, following the initial application on 1 January 2024 of the September 2024 edition of FRS 102.
DEMANDSCIENCE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 20 -
16
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:
Liabilities
Liabilities
2024
2023
Balances:
£
£
Accelerated capital allowances
35,483
55,050
2024
Movements in the year:
£
Liability at 1 January 2024
55,050
Credit to profit or loss
(19,567)
Liability at 31 December 2024
35,483
The deferred tax liability set out above relates to accelerated capital allowances that are expected to mature within the foreseeable future.
17
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
55,886
77,494
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
18
Share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
2
2
2
2
19
Financial commitments, guarantees and contingent liabilities
There is a cross- guarantee in favour of JP Morgan Chase Bank NA, between the company and fellow group companies:
comprising of a fixed and floating charge which covers all the bank borrowings of those companies.
DEMANDSCIENCE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 21 -
20
Related party transactions
The company's turnover relates wholly to sales of services to group companies.
The company has taken advantage of the exemption in section 33 of FRS 102 from disclosing transactions or balances between wholly owned group entities.
21
Ultimate controlling party
The immediate parent company is DemandScience Holdings UK Limited, a company registered in England & Wales. This is the UK group parent company responsible for preparing consolidated accounts.
The ultimate parent company is Thrasher Parent LLC, a company registered in the United States of America.
2024-12-312024-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.200Mr W B Harrigan JrMrs P J CarterMr G M JordanMr E N LeutzMr J Lin072775822024-01-012024-12-3107277582bus:Director22024-01-012024-12-3107277582bus:Director32024-01-012024-12-3107277582bus:Director42024-01-012024-12-3107277582bus:Director52024-01-012024-12-3107277582bus:Director12024-01-012024-12-3107277582bus:RegisteredOffice2024-01-012024-12-31072775822024-12-31072775822023-01-012023-12-310727758212024-01-012024-12-310727758212023-01-012023-12-3107277582core:RetainedEarningsAccumulatedLosses2023-01-012023-12-3107277582core:RetainedEarningsAccumulatedLosses2024-01-012024-12-31072775822023-12-3107277582core:LeaseholdImprovements2024-12-3107277582core:FurnitureFittings2024-12-3107277582core:ComputerEquipment2024-12-3107277582core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2024-12-3107277582core:LeaseholdImprovements2023-12-3107277582core:FurnitureFittings2023-12-3107277582core:ComputerEquipment2023-12-3107277582core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2023-12-3107277582core:ShareCapital2024-12-3107277582core:ShareCapital2023-12-3107277582core:RetainedEarningsAccumulatedLosses2024-12-3107277582core:RetainedEarningsAccumulatedLosses2023-12-3107277582core:ShareCapital2022-12-3107277582core:RetainedEarningsAccumulatedLosses2022-12-3107277582core:ShareCapital2023-12-3107277582core:ShareCapitalOrdinaryShareClass12024-12-3107277582core:ShareCapitalOrdinaryShareClass12023-12-3107277582core:LeaseholdImprovements2024-01-012024-12-3107277582core:FurnitureFittings2024-01-012024-12-3107277582core:ComputerEquipment2024-01-012024-12-3107277582core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2024-01-012024-12-3107277582core:UKTax2024-01-012024-12-3107277582core:UKTax2023-01-012023-12-3107277582core:LeaseholdImprovements2023-12-3107277582core:FurnitureFittings2023-12-3107277582core:ComputerEquipment2023-12-3107277582core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2023-12-31072775822023-12-3107277582core:CurrentFinancialInstruments2024-12-3107277582core:CurrentFinancialInstruments2023-12-3107277582core:Non-currentFinancialInstruments2024-12-3107277582core:Non-currentFinancialInstruments2023-12-3107277582core:WithinOneYear2024-12-3107277582core:WithinOneYear2023-12-3107277582core:BetweenTwoFiveYears2024-12-3107277582core:BetweenTwoFiveYears2023-12-3107277582core:MoreThanFiveYears2024-12-3107277582core:MoreThanFiveYears2023-12-3107277582bus:OrdinaryShareClass12024-01-012024-12-3107277582bus:OrdinaryShareClass12024-12-3107277582bus:OrdinaryShareClass12023-12-3107277582bus:PrivateLimitedCompanyLtd2024-01-012024-12-3107277582bus:FRS1022024-01-012024-12-3107277582bus:Audited2024-01-012024-12-3107277582bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP